Cohort (CHRT) Surges 12% on FY Beat — Leverage Scenarios & Defence Sector Read-Through

Published:

Data Snapshot

FY Revenue
£270m (vs £245m consensus, ~+10% beat)
Order Book
£616m (+19% YoY, 2.3x annual sales)
Adjusted EPS
54.44p (vs 46.1p forecast, ~+18% beat)
Adjusted EBIT
£27.5m (broadly in line)
Jefferies Price Target
1,290p (Hold)

Key Takeaways

  • Cohort's revenue beat consensus by ~10% (£270m vs £245m) and EPS by ~18% (54.44p vs 46.1p), with the order book hitting £616m — 2.3x annual sales vs a 1.6x long-term average.
  • EPS beat quality is mixed: approximately 18% outperformance includes a tax-charge reduction component, not pure operational leverage — traders should factor this into valuation re-rating expectations.
  • Leverage-specific risk: CHRT previously fell ~7.8% in a single session on weaker interim results; traders using >20x CFD leverage face liquidation from normal 3–5% intraday reversals on this name.
  • Cross-market read-through is limited to sector sentiment for UK/European defence tech; no meaningful impact on GBP, major indices (S&P 500, NASDAQ 100), or commodities.
  • Jefferies' 1,290p price target (initiated with 'hold') provides an institutional anchor; watch for consensus estimate upgrades in coming sessions as the key confirmation signal for sustained momentum.
The chart displays the performance of the S&P 500 Index (US500) over the last 24 hours, opening at 7514.85 and closing at 7541.85, marking a 0.36% increase. The index reached a high of 7543.05 and a low of 7500.65 during this period. Among related stocks, Boeing (BA) experienced a decline of 1.17%, while Raytheon Technologies (RTX) saw a modest increase of 0.62%. The Nasdaq 100 Index (US100) outperformed with a 1.48% rise, indicating a stronger performance in tech stocks compared to the broader market. This data highlights the mixed performance across sectors, with the S&P 500 showing slight gains amidst varying movements in individual stocks.
S&P 500 Index shows a 0.36% increase with mixed performances in related stocks.

According to Investing.com, Cohort plc (LON: CHRT) shares jumped sharply in London trading after the UK defence-technology group reported full-year results that materially beat consensus. Revenue came

Event Summary

According to Investing.com, Cohort plc (LON: CHRT) shares jumped sharply in London trading after the UK defence-technology group reported full-year results that materially beat consensus. Revenue came in at £270m versus a £245m forecast (~10% beat), while adjusted EPS hit 54.44p against a 46.1p estimate (~18% beat), partly aided by a lower-than-expected tax charge. Adjusted EBIT of £27.5m was broadly in line. The standout structural figure: the order book reached £616m, up 19% year-over-year and representing 2.3x annual sales — versus a long-term average of 1.6x. Jefferies has initiated coverage with a 'hold' rating and a 1,290p price target, per Fidelity's news feed.

Context matters here. An interim report earlier in the year showed profit down 17% despite revenue growth, as administrative and finance costs rose — the stock fell ~7.8% on that print. Today's full-year beat and order book strength therefore signals a potential execution inflection, justifying a sharper re-rating than a routine beat would warrant. This is part of the broader diversified sector earnings beat wave and sits squarely within the drone imaging & defense tech breakout theme.

Leverage Impact Analysis

Cohort is a UK-listed mid/small-cap stock. On CoinUnited.io, stock CFDs can be traded with up to 2000x leverage — but position sizing discipline is critical on a name that moved 12% intraday.

Worked example — long scenario: A trader opening a 50x long CHRT CFD at a notional entry price implying 1,290p (the Jefferies target as an anchor) with £1,000 margin controls £50,000 notional. A 12% upward move generates £6,000 gross profit — a 600% return on margin. However, the same position faces liquidation if price retraces just ~2% from entry (margin wiped at 1/50th of notional).

Key leverage risk: CHRT's prior 7.8% single-day drop on the interim results shows this stock can move sharply in both directions. Traders using >20x leverage on a name with this volatility profile face liquidation risk from normal intraday swings of 3–5%. The EPS beat quality is also mixed — roughly 18% EPS outperformance includes a tax-driven component, which is lower-quality earnings. If the market reprices this, a partial reversal could be swift.

For broader context on earnings beat sector playbooks and leverage strategies, position sizing relative to volatility is the primary risk lever. Monitor funding rates on CoinUnited.io and open interest for confirmation of directional conviction.

Cross-Market Impact

This is primarily a single-name, sector-sentiment catalyst with limited macro spillover. However, there are relevant read-throughs:

Defence peers: Cohort's 19% order book growth reinforces the elevated UK/European defence spending thesis. Larger defence primes like RTX Corporation and The Boeing Company operate in adjacent markets; while CHRT's scale doesn't move them, the sector sentiment confirmation is incrementally positive for the defence complex broadly.

Indices: CHRT's weighting in the NASDAQ 100 and S&P 500 is negligible — this is a UK AIM/small-cap name. No meaningful index-level impact is expected. UK small-cap defence-tech funds tracking similar names may see marginal sentiment lift.

FX & rates: At this scale, there is no meaningful GBP, gilt, or rates impact. The event is micro, not macro.

Trading Considerations

The Jefferies 1,290p price target provides a near-term institutional anchor. The 2.3x book-to-bill ratio (vs. 1.6x long-term average) is the key structural bullish datapoint — it supports multi-year revenue visibility and potential margin recovery. However, traders should weight the tax-driven component of the EPS beat as lower quality and watch whether analyst consensus upgrades follow in the coming days, which would confirm sustained momentum rather than a one-day event-driven spike.

Key risk: if broader UK equity sentiment or sector rotation turns risk-off, small-cap defence names typically underperform. Watch for any guidance commentary on cost trajectory given the prior interim margin compression.

Start Trading on CoinUnited.io

Create Your Free Account → — Trade crypto, stocks, forex, indices, and commodities with up to 2000x leverage and zero fees.

Frequently Asked Questions

Given CHRT's demonstrated ability to move 7–12% in a single session, leverage above 20x significantly compresses the liquidation buffer to under 5% from entry. Traders should size positions so that a 5–8% adverse move does not exceed their risk tolerance.

Disclaimer: This brief is for educational purposes only and is not investment advice.